Detailed genetic assessment of an oligosarcoma with retained IDH-mutation and 1p/19q codeletion at time of transformation

被引：0
|
作者：
Ziaei, A. [1 ]
Terry, M. [2 ]
Stoos, C. [3 ]
Perry, A. [1 ]
机构：
[1] Univ Calif San Francisco UCSF, Dept Pathol, Div Neuropathol, San Francisco, CA USA
[2] Univ Calif San Francisco UCSF, San Francisco, CA USA
[3] Methodist Hlth Syst, 8303 Dodge St, Omaha, NE 68114 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2023年 / 82卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
102
引用
收藏
页码：532 / 532
页数：1
相关论文
共 50 条
  • [31] Sensitive and specific detection of 1p/19q codeletion in gliomas by next generation sequencing
    Dubbink, E.
    Atmodimedjo, P. N.
    van Marion, R. M.
    Kros, J. M.
    van den Bent, M. J.
    Dinjens, W. N. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 53 - 53
  • [32] Care Setting Disparities in 1p/19q Codeletion Testing Rates for Diffuse Gliomas
    Torre, Matthew
    Lamba, Nayan
    Gupta, Sneha
    Smith, Timothy
    Iorgulescu, J. Bryan
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1623 - 1625
  • [33] 1p/19q codeletion and RET rearrangements in small-cell lung cancer
    Lu, Hongyang
    Xu, Haimiao
    Xie, Fajun
    Qin, Jing
    Han, Na
    Fan, Yun
    Mao, Weimin
    ONCOTARGETS AND THERAPY, 2016, 9 : 3571 - 3577
  • [34] RISK-ADJUSTED SURVIVAL OUTCOMES FOR AND FEATURES OF 1P/19Q CODELETION OLIGODENDROGLIOMAS
    Iorgulescu, B.
    Zogg, C.
    Gormley, W.
    Chiocca, E.
    Reardon, D.
    Wen, P.
    Haas-Kogan, D.
    Alexander, B.
    Ligon, K.
    Smith, T.
    NEURO-ONCOLOGY, 2017, 19 : 21 - 22
  • [35] Absence of 1p/19q codeletion in oligodendroglioma-like areas of pilocytic astrocytomas
    Frazer, Beth
    Kearney, Hugh
    Cryan, Jane
    Beausang, Alan
    Brett, Francesca
    Farrell, Michael A.
    Buckley, Patrick G.
    CLINICAL NEUROPATHOLOGY, 2018, 37 (04) : 182 - 185
  • [36] Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components
    Murakami, Chiaki
    Ikota, Hayato
    Nobusawa, Sumihito
    Nakata, Satoshi
    Yamazaki, Tatsuya
    Hashiba, Yasuhiro
    Hirato, Junko
    Yokoo, Hideaki
    PATHOLOGY INTERNATIONAL, 2020, 70 (01) : 40 - 46
  • [37] Care Setting Disparities in 1p/19q Codeletion Testing Rates for Diffuse Gliomas
    Torre, Matthew
    Lamba, Nayan
    Gupta, Sneha
    Smith, Timothy
    Iorgulescu, J. Bryan
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1623 - 1625
  • [38] Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
    Suzuki, Kenta
    Kawai, Nobuyuki
    Ogawa, Tomoya
    Miyake, Keisuke
    Shinomiya, Aya
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Tamiya, Takashi
    EJNMMI RESEARCH, 2021, 11 (01)
  • [39] Anaplastic Oligodendroglioma with IDH Mutation and 1p/19q Co-Deletion in a Patient with Ollier Disease
    Sadasivuni, Rajesh
    Rauschkolb, Paula
    NEUROLOGY, 2016, 86
  • [40] Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
    Pesenti, Chiara
    Paganini, Leda
    Fontana, Laura
    Veniani, Emanuela
    Runza, Letterio
    Ferrero, Stefano
    Bosari, Silvano
    Menghi, Maura
    Marfia, Giovanni
    Caroli, Manuela
    Silipigni, Rosamaria
    Guerneri, Silvana
    Tabano, Silvia
    Miozzo, Monica
    ONCOTARGET, 2017, 8 (34) : 57134 - 57148
12345